Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Yellow fever vaccine immunogenicity after hematopoietic stem cell transplant
RBR-28h68rqRecruiting
- Sponsor
- Evandro Chagas National Institute of Infectology
- Start
- Oct 2023
- Modality
- Live Attenuated Vaccines → Live Vaccines → Prophylactic Vaccines → Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Open-label, single-arm trial of 17D yellow fever vaccine in yellow fever, sponsored by Evandro Chagas National Institute of Infectology. Primary endpoint: Neutralizing antibody titer against yellow fever. Started Oct 2023; status: recruiting.
02
Drugs
17D yellow fever vaccine
03
Conditions
yellow fever
Beyond the preview
Go deeper on RBR-28h68rq.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on RBR-28h68rq.